BWAY - Brainsway announces insurance coverage by Israeli Ministry of Health

BrainsWay (NASDAQ:BWAY) has announced that, for the first time, the Israeli Ministry of Health has approved coverage applicable to its Deep TMS™ system for the treatment of depression. The inclusion of the treatment within Israel’s health basket of essential medical services means that the country’s health funds must now make the treatment available to qualifying patients free of charge. Coverage may be provided for up to 40 treatment sessions, which are to be administered in hospitals. "Facilitating insurance coverage through Israel’s health system is a key component of our growth strategy. We remain committed to further expanding insurance coverage in Israel and around the world in order to expand access to our groundbreaking treatment for the benefit of patients across the globe." said Dr. Christopher von Jako, President and CEO. BWAY +3.46% after hours to $5.38.

For further details see:

Brainsway announces insurance coverage by Israeli Ministry of Health